Prosecution Insights
Last updated: April 19, 2026

Tes Pharma S R L

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18201674 PYRIMIDINONE COMPOUNDS FOR TREATING ACUTE INFLAMMATION RODRIGUEZ, RAYNA B 1628 Non-Final OA May 24, 2023
17184431 HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6 SHTERENGARTS, SAMANTHA L 1623 Non-Final OA Feb 24, 2021

Managing Tes Pharma S R L's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month